Legends to Figures
FIGURE 1. EFS and OS rates from day 1 of treatment for all
patients (n = 41). EFS, event-free survival; OS, overall
survival.
FIGURE 2. EFS rates from day 1 of treatment for patients (A)
with good remission status (CR/VGPR) before HDC (n = 14) vs. poor
remission status (non-CR/VGPR) before HDC (n = 29) and (B) withMYCN amplification (n = 23) vs. MYCNnon-amplification (n = 20). EFS, event-free survival; OS, overall
survival; INRC, International Neuroblastoma Response Criteria; CR,
complete response; VGPR, very good partial response; HDC, high-dose
chemotherapy.